BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,031 filers reported holding BAXTER INTL INC in Q4 2014. The put-call ratio across all filers is 0.83 and the average weighting 0.5%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $566,000 | -85.5% | 7,032 | -84.5% | 0.10% | -87.2% |
Q2 2020 | $3,901,000 | +728.2% | 45,302 | +681.6% | 0.77% | +100.3% |
Q1 2020 | $471,000 | -83.2% | 5,796 | -82.7% | 0.38% | -6.8% |
Q4 2019 | $2,806,000 | +2.3% | 33,553 | +7.0% | 0.41% | -34.4% |
Q3 2019 | $2,743,000 | +438.9% | 31,358 | +404.6% | 0.63% | +556.2% |
Q2 2019 | $509,000 | -62.0% | 6,214 | -69.5% | 0.10% | -68.0% |
Q4 2018 | $1,339,000 | -19.2% | 20,348 | -5.4% | 0.30% | -4.8% |
Q3 2018 | $1,658,000 | -36.3% | 21,511 | -39.0% | 0.32% | -34.1% |
Q2 2018 | $2,604,000 | -4.8% | 35,269 | -16.2% | 0.48% | -17.7% |
Q1 2018 | $2,736,000 | +47.7% | 42,068 | +46.8% | 0.58% | +23.6% |
Q4 2017 | $1,852,000 | -10.4% | 28,654 | -13.1% | 0.47% | -14.2% |
Q3 2017 | $2,068,000 | -17.5% | 32,964 | -20.9% | 0.55% | -14.1% |
Q2 2017 | $2,508,000 | +24.6% | 41,679 | +7.4% | 0.64% | +12.9% |
Q1 2017 | $2,013,000 | +71.8% | 38,803 | +46.5% | 0.56% | +18.4% |
Q4 2016 | $1,172,000 | -18.4% | 26,480 | -13.4% | 0.48% | -9.3% |
Q3 2016 | $1,436,000 | +77.7% | 30,573 | +69.6% | 0.53% | +39.5% |
Q2 2016 | $808,000 | +8.0% | 18,022 | -0.5% | 0.38% | +30.0% |
Q1 2016 | $748,000 | -20.8% | 18,120 | -27.1% | 0.29% | +13.3% |
Q4 2015 | $945,000 | -25.0% | 24,843 | -35.2% | 0.26% | -58.7% |
Q3 2015 | $1,260,000 | -26.1% | 38,364 | +59.0% | 0.62% | +63.6% |
Q2 2015 | $1,705,000 | +49.0% | 24,133 | +44.7% | 0.38% | +21.1% |
Q1 2015 | $1,144,000 | +417.6% | 16,673 | +457.1% | 0.31% | +251.7% |
Q4 2014 | $221,000 | -49.1% | 2,993 | -49.6% | 0.09% | -75.0% |
Q1 2014 | $434,000 | – | 5,943 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soditic Asset Management LLP | 147,620 | $7,951,000 | 9.91% |
NUANCE INVESTMENTS, LLC | 5,429,702 | $292,444,000 | 6.51% |
Endurant Capital Management LP | 245,093 | $13,201,000 | 4.30% |
Veritas Asset Management LLP | 8,589,401 | $462,625,000 | 3.83% |
GENERATION INVESTMENT MANAGEMENT LLP | 11,876,040 | $639,644,000 | 3.80% |
Sivik Global Healthcare LLC | 120,000 | $6,463,000 | 3.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 480,500 | $25,880,000 | 3.31% |
Integral Health Asset Management, LLC | 300,000 | $16,158,000 | 3.14% |
Boothe Investment Group, Inc. | 89,078 | $4,798,000 | 3.11% |
Glenview Capital Management | 2,257,019 | $121,563,000 | 3.04% |